4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-027293
PRINCIPAL ACCOUNTING OFFICER sold 4,073 shares at $16.81 ($68,467)
- PRINCIPAL ACCOUNTING OFFICER acquired 7,930 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-11-17 | Option exercise | +3,965 | 19,971 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-11-17 | Option exercise | +3,965 | 23,936 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-11-19 | Sale | −4,073 | $16.81 | $68,467 | 19,863 | D |
| Derivatives | |||||||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-11-17 | Option exercise · Restricted Stock Units | −3,965 | 3,966 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2024-11-17 | Option exercise · Restricted Stock Units | −3,965 | 3,966 | D | ||
| Open-market sales · 4,073 sh · avg $16.81 · $68,467 | |||||||
Loading xslF345X05/form4-11202024_011147.xml…